Literature DB >> 14520723

Pseudomonas aeruginosa and cystic fibrosis: correlation between exoenzyme production and patient's clinical state.

P Lanotte1, L Mereghetti, B Lejeune, P Massicot, R Quentin.   

Abstract

In this study, we investigated the correlation between the production by Pseudomonas aeruginosa isolates of four exoenzymes (protease, elastase, neuraminidase, and phospholipase C (PLC)) and the clinical state of cystic fibrosis (CF) patients. We studied 212 P. aeruginosa isolates from 22 CF patients chronically infected with this bacterium. Patients were classified into three clinical groups according to a modified Shwachman-Kulczycki-Khaw (SKK) scoring system. The production of enzymes by isolates from patients in the three populations was analyzed and compared using four statistical tests: chi-square, Mann-Whitney U, principal component analysis, and discriminant analysis. Isolates from patients with excellent or good clinical status (group I, SKK score >/=71) had higher elastase and neuraminidase activities than isolates from the other patients. In contrast, PLC activity, a common characteristic of CF isolates, was higher in isolates from patients with poor or weak clinical status (group III, SKK score </=55). PLC also appeared to be the best parameter for differentiating between groups I and III. Enzyme production was highly variable in group II isolates (SKK score, 56-70). Our results suggest that P. aeruginosa isolates from patients with good clinical status produce large amounts of neuraminidase, and that PLC production may be involved in the decrease in pulmonary function. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520723     DOI: 10.1002/ppul.10380

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

1.  Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Authors:  Matthew J Wargo; Maegan J Gross; Sathish Rajamani; Jenna L Allard; Lennart K A Lundblad; Gilman B Allen; Michael L Vasil; Laurie W Leclair; Deborah A Hogan
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

2.  Cellular choline and glycine betaine pools impact osmoprotection and phospholipase C production in Pseudomonas aeruginosa.

Authors:  Liam F Fitzsimmons; Ken J Hampel; Matthew J Wargo
Journal:  J Bacteriol       Date:  2012-06-29       Impact factor: 3.490

3.  Pseudomonas aeruginosa Type III Secretion System Virulotypes and Their Association with Clinical Features of Cystic Fibrosis Patients.

Authors:  Edilene do Socorro Nascimento Falcão Sarges; Yan Corrêa Rodrigues; Ismari Perini Furlaneto; Marcos Vinicios Hino de Melo; Giulia Leão da Cunha Brabo; Kátia Cilene Machado Lopes; Ana Judith Pires Garcia Quaresma; Luana Nepomuceno Godim Costa Lima; Karla Valéria Batista Lima
Journal:  Infect Drug Resist       Date:  2020-10-22       Impact factor: 4.003

4.  Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.

Authors:  Pholawat Tingpej; Lucas Smith; Barbara Rose; Hua Zhu; Tim Conibear; Khaled Al Nassafi; Jim Manos; Mark Elkins; Peter Bye; Mark Willcox; Scott Bell; Claire Wainwright; Colin Harbour
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

5.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

6.  Choline catabolism to glycine betaine contributes to Pseudomonas aeruginosa survival during murine lung infection.

Authors:  Matthew J Wargo
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.